logo
搜索
菜单

的搜索结果

当前590/604页
排序: 总浏览数
13.20: Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance 01:25 min
13.20: Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
28.8: Elevation of Intermediate Points on Vertical Curves 01:20 min
28.8: Elevation of Intermediate Points on Vertical Curves
13.26: Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy 01:26 min
13.26: Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
10.5: In Vitro Drug Dissolution: Alternative Methods 01:17 min
10.5: In Vitro Drug Dissolution: Alternative Methods
7.20: Model Approaches for Pharmacokinetic Data: Physiological Models 01:15 min
7.20: Model Approaches for Pharmacokinetic Data: Physiological Models
6.7: Causes of Similarity-Dissimilarity Effect 01:26 min
6.7: Causes of Similarity-Dissimilarity Effect
17.2: Run Charts 01:12 min
17.2: Run Charts
13.18: Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment 01:08 min
13.18: Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
13.2: Drug Dosing: Obese Patients 01:21 min
13.2: Drug Dosing: Obese Patients
9.1: Accelerators 01:17 min
9.1: Accelerators
7.21: Physiological Pharmacokinetic Models: Assumption with Protein Binding 01:13 min
7.21: Physiological Pharmacokinetic Models: Assumption with Protein Binding
12.9: Drug Accumulation During Multiple Dosing: Intermittent IV Infusions 01:24 min
12.9: Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
12.3: Air-entraining Agents 01:27 min
12.3: Air-entraining Agents
13.15: Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow 01:26 min
13.15: Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
6.3: Role of Affect in Interpersonal Attraction 01:24 min
6.3: Role of Affect in Interpersonal Attraction
13.5: Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution 01:00 min
13.5: Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
13.4: Design Example: Managing Concrete Workability 01:14 min
13.4: Design Example: Managing Concrete Workability
16.3: Endocarditis III: Medical Management 01:18 min
16.3: Endocarditis III: Medical Management
9.4: Bioavailability Study Design: Single Versus Multiple Dose Studies 01:11 min
9.4: Bioavailability Study Design: Single Versus Multiple Dose Studies
5.13: Locus of Control 01:26 min
5.13: Locus of Control
返回顶部